STERiJECT® Low Dead Space (LDS) Needle: Zero-Waste Injection Architecture
Engineered by TSK Laboratory Japan, the patented STERiJECT® Low Dead Space (LDS) needle hub reduces dead space volume to near absolute zero. Officially certified by global pharmaceutical leaders including Pfizer and BioNTech for extracting maximum extra doses per vial, this ultra-rigid polymer needle eliminates expensive medication wastage, prevents leakage under pressure, and provides optimal clinician control.
< 0.001 ml
Up to 0.08 ml Saved
Up to 35% Lower
Rigid Non-Flex Polymer
Japanese Precision Engineering
Patented Technology & Clinical Superiority
Near-Zero Residual Dead Space
Patented internal geometry eliminates the medication trap present in conventional hubs, preventing product loss of up to 0.08 ml per syringe and generating massive operational savings in high-cost biologics and toxins.
TSKiD™ Enlarged Inner Diameter
Proprietary micro-thin wall technology provides an enlarged internal lumen. A 30G TSK needle flows with the ease of a 27G regular needle, reducing extrusion force by up to 35% for silky smooth plunger movement.
Ultra-Dense Hard Polymer Hub
Constructed from extremely dense medical-grade polymer that resists high injection pressures without flexing, preventing medication leakage and totally eliminating accidental needle pop-off.
Global Clinical Accreditation
Recognized and listed internationally by Pfizer and BioNTech as an authorized low dead space instrument capable of extracting vital extra doses from precious vaccine and biologic vials.
Comparative Technology
Visual Comparison: TSK Innovation vs. Conventional Needles
Observe the dramatic physical and hydro-dynamic advantages of TSK LDS engineering.
Technical Specifications



Reviews
There are no reviews yet.